These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 24549281

  • 1. Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure.
    Tasal A, Demir M, Kanadasi M, Bacaksiz A, Vatankulu MA, Sahin DY, Eker RA, Bozkurt A, Acarturk E.
    Med Sci Monit; 2014 Feb 19; 20():276-82. PubMed ID: 24549281
    [Abstract] [Full Text] [Related]

  • 2. Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure.
    Parissis JT, Adamopoulos S, Farmakis D, Filippatos G, Paraskevaidis I, Panou F, Iliodromitis E, Kremastinos DT.
    Heart; 2006 Dec 19; 92(12):1768-72. PubMed ID: 17105880
    [Abstract] [Full Text] [Related]

  • 3. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, Karatzas D, Gheorghiade M, Filippatos GS, Kremastinos DT.
    Am J Cardiol; 2006 Jul 01; 98(1):102-6. PubMed ID: 16784930
    [Abstract] [Full Text] [Related]

  • 4. Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.
    Bergh CH, Andersson B, Dahlström U, Forfang K, Kivikko M, Sarapohja T, Ullman B, Wikström G.
    Eur J Heart Fail; 2010 Apr 01; 12(4):404-10. PubMed ID: 20335355
    [Abstract] [Full Text] [Related]

  • 5. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators.
    Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, Hutchins S, Leier CV, LeJemtel TH, Loh E, Nicklas J, Ogilby D, Singh BN, Smith W.
    Circulation; 2000 Oct 31; 102(18):2222-7. PubMed ID: 11056096
    [Abstract] [Full Text] [Related]

  • 6. Duration of the beneficial effects of levosimendan in decompensated heart failure as measured by echocardiographic indices and B-type natriuretic peptide.
    McLean AS, Huang SJ, Nalos M, Ting I.
    J Cardiovasc Pharmacol; 2005 Dec 31; 46(6):830-5. PubMed ID: 16306809
    [Abstract] [Full Text] [Related]

  • 7. The predictive value of QRS duration in response to levosimendan therapy in patients with decompensated heart failure.
    Cetin M, Uçar O, Cicekçioğlu H, Güven Cetin Z, Sahin M, Vasfi Ulusoy F, Aydoğdu S.
    Acta Cardiol; 2012 Jun 31; 67(3):317-23. PubMed ID: 22870740
    [Abstract] [Full Text] [Related]

  • 8. Levosimendan: a calcium-sensitizing agent for the treatment of patients with decompensated heart failure.
    Lehtonen L.
    Curr Heart Fail Rep; 2004 Sep 31; 1(3):136-44. PubMed ID: 16036037
    [Abstract] [Full Text] [Related]

  • 9. Effects of levosimendan/furosemide infusion on plasma brain natriuretic peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients.
    Feola M, Lombardo E, Taglieri C, Vallauri P, Piccolo S, Valle R.
    Med Sci Monit; 2011 Feb 25; 17(3):PI7-13. PubMed ID: 21358614
    [Abstract] [Full Text] [Related]

  • 10. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
    Parissis JT, Paraskevaidis I, Bistola V, Farmakis D, Panou F, Kourea K, Nikolaou M, Filippatos G, Kremastinos D.
    Am J Cardiol; 2006 Dec 01; 98(11):1489-92. PubMed ID: 17126656
    [Abstract] [Full Text] [Related]

  • 11. Effects of levosimendan on TNF-alpha, BNP and MMP-1 in patients with heart failure with anemia.
    Büyüklü M, Kürüm AT, Tatlý E, Set T.
    Arq Bras Cardiol; 2012 Jul 01; 99(1):659-64. PubMed ID: 22735864
    [Abstract] [Full Text] [Related]

  • 12. Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation.
    Zemljic G, Bunc M, Yazdanbakhsh AP, Vrtovec B.
    J Card Fail; 2007 Aug 01; 13(6):417-21. PubMed ID: 17675054
    [Abstract] [Full Text] [Related]

  • 13. [The effect of levosimendan and dobutamine treatment on QT dispersion in patients with decompensated heart failure: a prospective study].
    Paksoy F, Ulaş T, Tursun I, Dal MS, Oztekin E, Borlu F.
    Anadolu Kardiyol Derg; 2012 Feb 01; 12(1):16-22. PubMed ID: 22214738
    [Abstract] [Full Text] [Related]

  • 14. Effects of levosimendan on heart failure in normotensive patients: does loading dose matter?
    Palmerini E, Söderberg S, Mondillo S, Favilli R, Lunghetti S.
    Acute Card Care; 2015 Mar 01; 17(1):14-9. PubMed ID: 25806830
    [Abstract] [Full Text] [Related]

  • 15. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
    Kivikko M, Lehtonen L.
    Curr Pharm Des; 2005 Mar 01; 11(4):435-55. PubMed ID: 15725064
    [Abstract] [Full Text] [Related]

  • 16. Acute effects of levosimendan on mitral regurgitation and diastolic function in patients with advanced chronic heart failure.
    Branzi G, Malfatto G, Villani A, Ciambellotti F, Revera M, Giglio A, Rosa FD, Facchini M, Parati G.
    J Cardiovasc Med (Hagerstown); 2010 Sep 01; 11(9):662-8. PubMed ID: 20613551
    [Abstract] [Full Text] [Related]

  • 17. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure.
    Nieminen MS, Akkila J, Hasenfuss G, Kleber FX, Lehtonen LA, Mitrovic V, Nyquist O, Remme WJ.
    J Am Coll Cardiol; 2000 Nov 15; 36(6):1903-12. PubMed ID: 11092663
    [Abstract] [Full Text] [Related]

  • 18. Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.
    Duman D, Palit F, Simsek E, Bilgehan K, Sacide A.
    Can J Cardiol; 2009 Oct 15; 25(10):e353-6. PubMed ID: 19812809
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of dobutamine-induced changes of the two-dimensional longitudinal deformation predict clinical and neurohumoral improvement in men after levosimendan treatment in acutely decompensated chronic heart failure.
    Paraskevaidis IA, Bistola V, Ikonomidis I, Parissis JT, Papadopoulos C, Filippatos G, Kremastinos DT.
    Am J Cardiol; 2008 Nov 01; 102(9):1225-9. PubMed ID: 18940297
    [Abstract] [Full Text] [Related]

  • 20. Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failure.
    Parissis JT, Panou F, Farmakis D, Adamopoulos S, Filippatos G, Paraskevaidis I, Venetsanou K, Lekakis J, Kremastinos DT.
    Am J Cardiol; 2005 Aug 01; 96(3):423-6. PubMed ID: 16054474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.